|
2003 Journal Article Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: Presentation of MART1 to CD8+ T cellsRadford, KJ, Jackson, AM, Wang, JH, Vassaux, G and Lemoine, NR (2003). Recombinant E. coli efficiently delivers antigen and maturation signals to human dendritic cells: Presentation of MART1 to CD8+ T cells. International Journal of Cancer, 105 (6), 811-819. doi: 10.1002/ijc.11149 |
|
2002 Journal Article A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapyRadford, K. J., Higgins, D. E., Pasquini, S., Cheadle, E. J., Carta, L., Jackson, A. M., Lemoine, N. R. and Vassaux, G. (2002). A recombinant E. coli vaccine to promote MHC class I-dependent antigen presentation: application to cancer immunotherapy. Gene Therapy, 9 (21), 1455-1463. doi: 10.1038/sj.gt.3301812 |
|
1997 Journal Article Immunogenicity of CD63 in a patient with melanomaSmith, Melanie, Bleijs, Rik, Radford, Kristen and Mersey, Peter (1997). Immunogenicity of CD63 in a patient with melanoma. Melanoma Research, 7 (SUPPL. 2) |
|
1997 Journal Article Regulation of tumor cell motility and migration by CD63 in a human melanoma cell lineRadford, KJ, Thorne, RF and Hersey, P (1997). Regulation of tumor cell motility and migration by CD63 in a human melanoma cell line. Journal of Immunology, 158 (7), 3353-3358. |
|
1996 Journal Article CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanomaRadford, KJ, Thorne, RF and Hersey, P (1996). CD63 associates with transmembrane 4 superfamily members, CD9 and CD81, and with β1 integrins in human melanoma. Biochemical and Biophysical Research Communications, 222 (1), 13-18. doi: 10.1006/bbrc.1996.0690 |
|
1995 Journal Article Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491)Radford, KJ, Mallesch, J and Hersey, P (1995). Suppression of human melanoma cell growth and metastasis by the melanoma-associated antigen CD63 (ME491). International Journal of Cancer, 62 (5), 631-635. doi: 10.1002/ijc.2910620523 |
